A Single Dose Study of MK-6194 in Healthy Chinese Participants (MK-6194-014)
Clinical trial NCT06821334 · COMPLETED
Trial details
- NCT number
- NCT06821334
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-23
- Primary completion
- 2024-08-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.